Policy

ONDCP Deputy Director Leary and Dr. Campopiano will speak about the Obama Administration’s 21st Century approach to drug policy regarding opioid use disorders and overdose. With the alarming uptick in opioid overdose deaths and the high rate of overdose deaths among those reentering the community, this webinar will address the effect opioids have on the brain, the different types of medication assisted treatment (MAT), and the importance of having a comprehensive approach to opioid use disorders which includes MAT, overdose prevention, and continuity of care.

Strickler and Reynolds prepared an invited webinar on the PBSS secure online Data Portal for authorized federal researchers. Authorized federal researchers from the CDC, FDA and ASPE were invited to a webinar to review the DUA and instructions on connecting to and using the Data Portal.

Conducted regular PBSS Oversight Committee meetings, including participants from CDC, FDA, BJA, SAMHSA, the PDMP participating states and the PDMP Training and Technical Assistance Center.

Two Center staff members presented "Responses to Underage Drinking" with Dr. Ken Winters, Director of the Center for Adolescent Substance Abuse Research. The presentation was addressed to judges, court staff, administrators, law enforcement, probation, prosecutors, defense attorneys, social services, tribal HTWC Staff

Technical assistance with the implementation of The Drug Market Intervention evidence-based model. This engagement consisted of one day of training, and one day of individual follow-up meetings with stakeholder agencies. Training participants consisted of mainly Camden County Police Department officers (and other ranks), other Camden County personnel, as well as members from the Newark (NJ) VRN site, Wilmington (DE) VRN site, and West Memphis (AR) VRN site.

While the Access to Treatment project initially focused on connections to post-release addictions treatment, the focus of this meeting will be on how to improve pre-release strategies to more efficiently and effectively connect people to treatment. Essential pre-release components of a comprehensive continuity of care strategy include: identification of individual treatment needs, analysis of the criminal justice system capacity for treatment, engagement in pre-release interventions, and reentry planning.

Delivered two training sessions at the Southern Oregon Pain Conference.

The PDMP TTAC Website www.pdmpassist.org is sent through the listserv. The target audience is PDMP Administrators’ and agencies or organizations interested in issues related to the effective use of PDMPs to curb prescription drug misuse and abuse. The May Newsletter Volume 7, Issue 3 highlighted the following topics ADHD and Doctor Shopping and State Action to Prevent and Treat Prescription Drug Abuse.We have also added a Treatment/Prevention Corner and a new section on the latest PDMP Legislation to the newsletters.

The PDMP TTAC Website www.pdmpassist.org is sent through the listserv. The target audience is PDMP Administrators’ and agencies or organizations interested in issues related to the effective use of PDMPs to curb prescription drug misuse and abuse.

The PDMP TTAC Website www.pdmpassist.org is sent through the listserv. The target audience is PDMP Administrators’ and agencies or organizations interested in issues related to the effective use of PDMPs to curb prescription drug misuse and abuse. The January Newsletter Volume 7, Issue 1 focus was on Research on Doctor Deception: The Journal of the American Board of Family Medicine published study, “Deception for Drugs: Self-Reported ‘Doctor Shopping’ Among Young Adults”.